128 related articles for article (PubMed ID: 7534027)
1. Interferon alpha-2a in the treatment of exudative senile macular degeneration.
Jaakkola A; Anttila PM; Immonen I
Acta Ophthalmol (Copenh); 1994 Oct; 72(5):545-9. PubMed ID: 7534027
[TBL] [Abstract][Full Text] [Related]
2. Interferon alfa-2a is ineffective for patients with choroidal neovascularization secondary to age-related macular degeneration. Results of a prospective randomized placebo-controlled clinical trial. Pharmacological Therapy for Macular Degeneration Study Group.
Arch Ophthalmol; 1997 Jul; 115(7):865-72. PubMed ID: 9230826
[TBL] [Abstract][Full Text] [Related]
3. Clinical experience with interferon alfa-2a for exudative age-related macular degeneration.
Kirkpatrick JN; Dick AD; Forrester JV
Br J Ophthalmol; 1993 Dec; 77(12):766-70. PubMed ID: 7509185
[TBL] [Abstract][Full Text] [Related]
4. Treatment of choroidal neovascularization in age-related macular degeneration with interferon alpha-2a: a short term, nonrandomized pilot study.
Thoelen A; Menozzi M; Huber C; Messmer E
Ger J Ophthalmol; 1995 May; 4(3):137-43. PubMed ID: 7545047
[TBL] [Abstract][Full Text] [Related]
5. Factors influencing visual acuity after photocoagulation for subfoveal choroidal neovascularization of exudative age-related macular degeneration.
Yuzawa M; Tamakoshi A; Ueha M; Kawakubo H; Nakajima M
Ophthalmology; 1996 Dec; 103(12):2037-41. PubMed ID: 9003337
[TBL] [Abstract][Full Text] [Related]
6. Scatter macular photocoagulation for subfoveal neovascular membranes in age-related macular degeneration. A pilot study.
Tornambe PE; Poliner LS; Hovey LJ; Taren D
Retina; 1992; 12(4):305-14. PubMed ID: 1283021
[TBL] [Abstract][Full Text] [Related]
7. Interferon alfa-2a in the treatment of subfoveal choroidal neovascularization.
Thomas MA; Ibanez HE
Am J Ophthalmol; 1993 May; 115(5):563-8. PubMed ID: 7683842
[TBL] [Abstract][Full Text] [Related]
8. Interferon alpha-2a for subfoveal neovascularization in age-related macular degeneration.
Poliner LS; Tornambe PE; Michelson PE; Heitzmann JG
Ophthalmology; 1993 Sep; 100(9):1417-24. PubMed ID: 8371932
[TBL] [Abstract][Full Text] [Related]
9. Radiation therapy for subfoveal choroidal neovascular membranes in age-related macular degeneration. A pilot study.
Bergink GJ; Deutman AF; van den Broek JF; van Daal WA; van der Maazen RW
Graefes Arch Clin Exp Ophthalmol; 1994 Oct; 232(10):591-8. PubMed ID: 7528158
[TBL] [Abstract][Full Text] [Related]
10. Treatment of choroidal neovascularisation in age-related macular degeneration with interferon alfa-2a and alfa-2b.
Gillies MC; Sarks JP; Beaumont PE; Hunyor AB; McKay D; Kearns M; McClusky PJ; Sarks SH
Br J Ophthalmol; 1993 Dec; 77(12):759-65. PubMed ID: 7509184
[TBL] [Abstract][Full Text] [Related]
11. ICGA-guided laser photocoagulation of feeder vessels of choroidal neovascular membranes in age-related macular degeneration. Indocyanine green angiography.
Desatnik H; Treister G; Alhalel A; Krupsky S; Moisseiev J
Retina; 2000; 20(2):143-50. PubMed ID: 10783946
[TBL] [Abstract][Full Text] [Related]
12. Foveal sparing photocoagulation for exudative age-related macular degeneration.
Orth DH; Rosculet JP; De Bustros S
Retina; 1994; 14(2):153-9. PubMed ID: 7518606
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal interferon alpha-2b for the treatment of neovascular age-related macular degeneration: a pilot study.
Kertes PJ; Britton WA; Leonard BC
Can J Ophthalmol; 1997 Apr; 32(3):185-8. PubMed ID: 9131284
[No Abstract] [Full Text] [Related]
14. Five-year follow-up of fellow eyes of patients with age-related macular degeneration and unilateral extrafoveal choroidal neovascularization. Macular Photocoagulation Study Group.
Arch Ophthalmol; 1993 Sep; 111(9):1189-99. PubMed ID: 7689826
[TBL] [Abstract][Full Text] [Related]
15. Interferon alpha-2a treatment of patients with subfoveal neovascular macular degeneration. A pilot investigation.
Engler CB; Sander B; Koefoed P; Larsen M; Vinding T; Lund-Andersen H
Acta Ophthalmol (Copenh); 1993 Feb; 71(1):27-31. PubMed ID: 7682747
[TBL] [Abstract][Full Text] [Related]
16. The treatment of choroidal neovascular membranes by alpha interferon. An efficacy and toxicity study.
Chan CK; Kempin SJ; Noble SK; Palmer GA
Ophthalmology; 1994 Feb; 101(2):289-300. PubMed ID: 7509472
[TBL] [Abstract][Full Text] [Related]
17. Submacular surgery trials randomized pilot trial of laser photocoagulation versus surgery for recurrent choroidal neovascularization secondary to age-related macular degeneration: I. Ophthalmic outcomes submacular surgery trials pilot study report number 1.
Bressler NM; Bressler SB; Hawkins BS; Marsh MJ; Sternberg P; Thomas MA;
Am J Ophthalmol; 2000 Oct; 130(4):387-407. PubMed ID: 11024412
[TBL] [Abstract][Full Text] [Related]
18. Comparisons of photocoagulation treatment in exudative age-related macular degeneration with the blue-green argon, green argon and red krypton laser wavelengths.
Atmaca LS; Ozmert E; Gündüz K
Ophthalmologica; 1993; 207(1):46-54. PubMed ID: 7506402
[TBL] [Abstract][Full Text] [Related]
19. Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration. Updated findings from two clinical trials. Macular Photocoagulation Study Group.
Arch Ophthalmol; 1993 Sep; 111(9):1200-9. PubMed ID: 7689827
[TBL] [Abstract][Full Text] [Related]
20. The application of the macular photocoagulation study eligibility criteria for laser treatment in age-related macular degeneration.
Gelfand YA; Linn S; Miller B
Ophthalmic Surg Lasers; 1997 Oct; 28(10):823-7. PubMed ID: 9336775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
